- Home
- FTNT vs ZTS Comparison
FTNT vs ZTS Comparison
Compare FTNT & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTNT
- ZTS
- Stock Information
- Founded
- FTNT 2000
- ZTS 1952
- Country
- FTNT United States
- ZTS United States
- Employees
- FTNT N/A
- ZTS N/A
- Industry
- FTNT Computer peripheral equipment
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- FTNT Technology
- ZTS Health Care
- Exchange
- FTNT Nasdaq
- ZTS Nasdaq
- Market Cap
- FTNT 80.1B
- ZTS 75.1B
- IPO Year
- FTNT 2009
- ZTS 2013
- Fundamental
- Price
- FTNT $99.85
- ZTS $157.13
- Analyst Decision
- FTNT Buy
- ZTS Buy
- Analyst Count
- FTNT 32
- ZTS 8
- Target Price
- FTNT $106.93
- ZTS $211.50
- AVG Volume (30 Days)
- FTNT 4.5M
- ZTS 2.8M
- Earning Date
- FTNT 08-05-2025
- ZTS 08-05-2025
- Dividend Yield
- FTNT N/A
- ZTS 1.27%
- EPS Growth
- FTNT 57.71
- ZTS 7.32
- EPS
- FTNT 2.43
- ZTS 5.57
- Revenue
- FTNT $6,142,200,000.00
- ZTS $9,286,000,000.00
- Revenue This Year
- FTNT $15.79
- ZTS $3.54
- Revenue Next Year
- FTNT $12.92
- ZTS $6.11
- P/E Ratio
- FTNT $41.09
- ZTS $28.22
- Revenue Growth
- FTNT 13.83
- ZTS 6.32
- 52 Week Low
- FTNT $54.57
- ZTS $139.70
- 52 Week High
- FTNT $114.82
- ZTS $200.33
- Technical
- Relative Strength Index (RSI)
- FTNT 43.43
- ZTS 39.98
- Support Level
- FTNT $100.31
- ZTS $154.54
- Resistance Level
- FTNT $104.50
- ZTS $168.83
- Average True Range (ATR)
- FTNT 2.44
- ZTS 3.41
- MACD
- FTNT -0.34
- ZTS -1.67
- Stochastic Oscillator
- FTNT 15.62
- ZTS 12.41
About FTNT Fortinet Inc.
Fortinet is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, zero-trust access, and security operations. The firm derives a majority of its revenue through sales of its subscriptions and support-based business. The California-based firm has more than 800,000 customers across the world.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.